News and applications for life science research professionals
GlaxoSmithKline says no China bribery found
June 13, 2013 2:58 am | by The Associated Press | News | CommentsDrug manufacturer GlaxoSmithKline said Thursday it has investigated an accusation that its salespeople in China bribed doctors and found no evidence of wrongdoing. The company said it conducted a four-month investigation after receiving complaints from an anonymous source. It said it found "no...
Girl who took on transplant rules gets new lungs
June 13, 2013 2:53 am | by KEITH COLLINS - Associated Press - Associated Press | News | CommentsA 10-year-old girl ailing with cystic fibrosis was recovering from a transplant of adult lungs made available to her by a judge's controversial ruling that expanded her options for lifesaving surgery. Sarah Murnaghan underwent a six-hour surgery Wednesday at Children's Hospital of Philadelphia, a...
Idaho farmers sue Monsanto over GMO wheat
June 12, 2013 5:35 pm | by REBECCA BOONE - Associated Press - Associated Press | News | CommentsFarmers in Idaho have filed a potentially class action lawsuit against seed giant Monsanto after genetically engineered wheat was found in an eastern Oregon field. The farmers, represented by a Boise law firm, filed the federal lawsuit Friday contending that Monsanto's development of Roundup...
HIV Treatment Can Protect Injection Drug Users
June 12, 2013 3:06 pm | by MIKE STOBBE - AP Medical Writer - Associated Press | News | CommentsDoctors should consider giving a daily AIDS drug to another high risk group to help prevent infections - people who shoot heroin, methamphetamines or other injection drugs, U.S. health officials say. A similar recommendation is already in place for gay men and heterosexual couples at high risk of catching HIV, the virus that causes AIDS.
The Collaborative RNA Dream
June 12, 2013 2:28 pm | by Christina Smith | Articles | CommentsYesterday, the RNA Institute at New York’s State University at Albany opened its doors to reveal a space that has been four years in the making: a newly expanded facility totaling 25,000 square feet, equipped with millions of dollars of laboratory equipment and constructed with a novel goal in mind – to foster collaboration on RNA research among researchers across the nation.
Wireless Pulse Counting Data Logger
June 12, 2013 1:36 pm | Product Releases | CommentsTandD Corp. has introduced the RTR-505P Wireless Pulse Counting Data Logger. This new model can record pulses from devices such as flow meters, anemometers, or the opening and closing of switches from a variety of sensors.
Amgen says ovarian cancer drug met study goal
June 12, 2013 12:45 pm | by The Associated Press | News | CommentsTHOUSAND OAKS, Calif. (AP) — Biotech drugmaker Amgen Inc. reported Wednesday that its experimental drug for ovarian cancer helped patients live 1.8 months longer without their disease spreading, compared with patients getting placebo. The difference was large enough to meet the study's primary...
UK to start regulating e-cigarettes as medicines
June 12, 2013 11:43 am | by MARIA CHENG - AP Medical Writer - Associated Press | News | CommentsBritain will start regulating electronic cigarettes and other products containing nicotine as medicines, according to the country's top regulator. E-cigarettes are battery-operated products that turn nicotine into a vapor that is inhaled by the user. In a statement Wednesday, the Medicines and...
Celgene reports results for arthritis drug
June 12, 2013 11:40 am | by The Associated Press | News | CommentsCelgene Corp. said Wednesday a one-year study of its experimental drug for psoriatic arthritis showed "meaningful improvements" in patients' symptoms. Psoriatic arthritis is a form of arthritis that causes joint pain, stiffness and swelling in patients with psoriasis. The company said patients...
Cytokinetics and Amgen expand collaboration
June 12, 2013 11:30 am | by The Associated Press | News | CommentsCytokinetics Inc. and Amgen Inc. said Wednesday that they are expanding their collaboration on a drug to treat heart failure in a deal worth at least $25 million. The development and marketing agreement now includes Japan, meaning it covers all countries. Cytokinetics said Amgen will make an...
Airlift Bioreactor Simplifies Cell Culture, Fermentation
June 12, 2013 10:43 am | Product Releases | CommentsCellexus manufactures the CellMaker, an easy-to-use, single-use, disposable, airlift bioreactor system. The Cellexus technology applies an inexpensive state-of-the-art airlift methodology designed to simplify cell culture and fermentation in bioresearch, scale-up, production and manufacturing.
Proteomics Nails Metastasis Mystery
June 12, 2013 10:33 am | News | CommentsMalignant cells can escape from primary tumors and colonize new sites in other tissues. In a new study, researchers show how the transcription factor AP4 promotes the development of such metastatic tumors. With the aid of genome-wide characterization of AP4’s target genes and direct functional tests, researchers uncovered processes relevant to tumorigenesis and cancer progression that are triggered by the protein.
Newly Identified Heart Channel Controls Beat
June 12, 2013 10:19 am | News | CommentsThe heart's regular rhythm is regulated by a bundle of cells called "the pacemaker." Previously, scientists found that many cases of inherited arrhythmias originating in the pacemaker could be attributed to functional defects in the channels responsible for the flow of sodium and calcium. Now, researchers have discovered a previously unidentified potassium channel in the cardiac pacemaker which helps to regulate the heartbeat.
Genes Behind Fruit Ripening Revealed
June 12, 2013 9:53 am | News | CommentsIt's common wisdom that one rotten apple in a barrel spoils all the other apples, and that an apple ripens a green banana if they are put together in a paper bag. Ways to ripen, or spoil, fruit have been known for thousands of years. Now, scientists have traced the thousands of genes in a plant that are activated once ethylene gas is released.
Pfizer settles Protonix patent case for $2.15B
June 12, 2013 9:39 am | by The Associated Press | News | CommentsTwo generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., one of the world's largest generic drugmakers, will pay $1.6 billion, while India's Sun Pharmaceutical Industries...
